Coinciding with the JP Morgan Global Healthcare Conference.

It is insensitive to the variants of instruments, laboratories and sample quality. SNAQ technology also allows bench top complicated molecular screening of limited and degraded samples. Thus AccuGenomics’ quantitative, reproducible and accurate numerical gene expression measurements are unparalleled. During 2012, AccuGenomics will be going after FDA authorization for its standardized check for Chronic Myeoloid Leukemia treatment monitoring, in collaboration with Tumor Genetics, Inc.With 99 % coverage of human being genes and 95 % insurance coverage of transcript isoforms, experts determined that the high density microarray is definitely an improved profiling array for medical research. ‘With unparalleled sensitivity, reproducibility, and simplicity, arrays of this type shall be the platform of choice for patient profiling in scientific trials, ‘ said Stanford Professor of Genetics and Biochemistry Ronald W.